Nephrectomy and IVC thrombectomy in renal cancer: a narrative review

Faegh, Ali; Moeinafshar, Aysan; Rezaei, Nima

doi:10.1007/s12094-023-03302-6

Cited by 3 publications

(2 citation statements)

References 62 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…about 16% of TNETs are associated with testicular teratoma. 2,6 Same as other testicular tumors, ultrasound is an available and accurate modality for pre-operative evaluation. However, abdominopelvic magnetic resonance imaging (MRI) and CT-scan can be used to find other sites metastasis.…”

Section: Outcome and Follow-upmentioning

confidence: 99%

Testicular neuroendocrine tumor in a 32‐year‐old man: A case report

Dehghaniathar,

Moradi,

Emtiazi

2024

Clinical Case Reports

View full text Add to dashboard Cite

Key Clinical MessageA 32‐year‐old male with painful scrotal swelling who underwent radical orchiectomy and was diagnosed with a testicular neuroendocrine tumor. Determining whether testicular neuroendocrine tumor is primary or metastasis from another origin is crucial.AbstractTesticular neuroendocrine tumors (TNET) are one of the rarest human neoplasms, with about 132 identified cases until 2015. Testicular neuroendocrine tumors are frequently manifest with painless scrotal swelling or mass. In this study, we present a 32‐year‐old male with a chief complaint of painful progressive swelling of the right testicle without any history of trauma. All laboratory tests were within the normal range. Ultrasound revealed two hyper‐vascular masses in the right testicle. Computed tomography was performed, and patients had no evidence of metastases. The patient underwent right radical orchiectomy, and a histopathological examination diagnosed the specimen with a well‐differentiated testicular neuroendocrine tumor. Because of the rarity of TNET, there are many controversial issues in the treatment, especially in cases with metastatic TNET. Determining whether testicular neuroendocrine tumor is primary or metastasis from another origin is crucial. Further studies are required to achieve optimum treatment for TNET.

show abstract

Section: Outcome and Follow-upmentioning

confidence: 99%

Testicular neuroendocrine tumor in a 32‐year‐old man: A case report

Dehghaniathar,

Moradi,

Emtiazi

2024

Clinical Case Reports

View full text Add to dashboard Cite

show abstract

“…For many years, open surgery was the only option for patients with RCC with IVC extension, especially for cases that required suprahepatic or intrathoracic IVC visualization. The minimally invasive approach to robotic-associated radical nephrectomy with IVC tumor thrombectomy (RARN/IVCTT) is a complex surgery that has significant risk of mortality and morbidity, akin to the open approach, and requires a highly-skilled multidisciplinary team [ 15 ]. While the first laparoscopic nephrectomy was performed by Clayman et al in 1990 [ 16 ], Abaza reported the first case series of robotic nephrectomies requiring IVC cross-clamping in 2011 [ 17 ].…”

Section: Introductionmentioning

confidence: 99%

A Narrative Review on Robotic Surgery as Treatment for Renal Cell Carcinoma with Inferior Vena Cava Thrombus

Shah,

Wang,

Shah

et al. 2024

JCM

View full text Add to dashboard Cite

Renal cell carcinoma (RCC) is a common diagnosis, of which a notable portion of patients present with an extension into the venous circulation causing an inferior vena cava (IVC) tumor thrombus. Venous extension has significant implications for staging and subsequent treatment planning, with recommendations for more aggressive surgical removal, although associated surgical morbidity and mortality is relatively increased. The methods for surgical removal of RCC with IVC thrombus remain complex, particularly surrounding the use of robot-assisted surgery. Robot assistance for radical nephrectomy in this context is recently emerging. Thrombus level has important implications for surgical technique and prognosis. Other preoperative considerations may include location, laterality, size, and wall invasion. The urology literature on treatment of such tumors is largely limited to case series and institutional studies that describe the feasibility of various surgical options for these complex tumors. Further understanding of the outcomes and patient-specific risk factors would shed increased light on the optimal treatment for such cases. This narrative review provides a thorough overview on the previously reported use of robot-assisted nephrectomy in RCC with IVC thrombus to inform further studies which may optimize outcomes and guide shared decision-making.

show abstract